Dormehl I. C., Jordaan B., Oliver D. W., Croft S. SPECT
Monitoring of improved cerebral blood flow during longterm
treatment of elderly patients with nootropic drugs //
Clin. Nucl. Med. — 1999. — N 2 4(1). — Р . 29 – 4.
237. Eckel K. Ü ber die Unterst ü tzung der Therapie der Depression
Mit Gehirnhydrolysat // II Symposium on Cerebrolysin.
— M., 1975. — Р . 62 – 5.
Eckel K. Therapeutische Wirkung von Gehirnhydrolysaten
bei depressions-bedingten Intelligenzst ö rungen // Wien.
Med. Wochenschr. — 1977. — N 127(2). — Р . 85 – 8.
Eder P., Reinprecht I., Schreiner E. et al. Increased
Density of glutamate receptor subunit 1 due to Cerebrolysin
Treatment: an immunohistochemical study on
Aged rats // Histochem. J. — 2001. — N 33 (11 – 2). — par Р . 605 – 12.
Faist E. Consequences of Trauma, Shock and Sepsis. — par Munich, 2000. — P. 243 – 48.
Fei Z., Yi S. Change of free radicals in the plasma of patients
With cranio-cerebral trauma and therapeutical effect
Of Cerebrolysin // Chin. J. Nerv. Ment. Dis. — 1992. — par N 18. — Р . 6.
Ferrari A., Pasciullo G., Savino G. et al. Headache treatment
Before and after the consultation of a specialized
Center: a pharmacoepidemiology study // Headache. — par 2004. — N 24. — Р . 356 – 60.
Francis-Turner L., Valouskova V. Nerve growth factor and
Nootropic drug Cerebrolysin but not fibroblast growth factor
Can reduce spatial memory impairment elicited by fimbriafornix
Transection: shortterm study // Neurosci. Lett.
— 1996. — Vol. 202. — P. 193 – 96.
Francis-Turner L., Valouskova V., Morky J. Longterm effect
Of NGF, bFGF and Cerebrolysin on the spatial memory
After fimbriafornix lesion in rats // J. Neural. Trasm. — par 1996. — Vol. 47 (Suppl. ). — P. 277.
Funke M., Fiehler J., Mewes I. et al. Dosedependent effects
Of Cerebrolysin on EEG and short term memory of
Healthy volunteers during control and hyperventilation induced
Cerebral ischemia // J. Neural. Transm. — 1998. — par Vol. 53 (Suppl. ). — P. 385 – 98.
Gauthier S. Results of a 6month randomized placebocontrolled
Study with Cerebrolysin in Alzheimers disease // Europ.
J. Neurol. — 1999. — Vol. 6, suppl. 3. — P. 28.
|
|
|
Gonzalez M. E., Francis L., Castellano O. Antioxidant systemic
Effect of shortterm Cerebrolysin administration // J.
Neural. Transm. — 1998. — Vol. 53 (Suppl. ). — P. 333 – 41.
Gorbachevskaya N., Bashina V., Gratchev V., Iznak A.
Cerebrolysin therapy in Rett syndrome: clinical and EEG
Mapping study // Brain Dev. — 2001. — N 23, Suppl 1. — par S90 – 93.
Grundman M., Corey-Bloom J., Thal L. J. Perspectives
In clinical Alzheimer ’ s disease research and the development
Of antidementia drugs // J. Neural. Transm. Suppl. — par 1998. — N 53. — Р . 255 – 75.
Gromova O. A., Skalny A. V., Sotnikova N. Yu., Bykov A. T.
Cerebrolysin correction deficiency of trace element ’ s and
Disorders of immune status of children with minimal cerebral
Dysfunction1 // 1-st International FESTEM Congress
On Trace Elements and Minerals in Medicine and Biology,
May 16 – 9 2001, Venice, Italy. — 2001. — Р . 158.
Gromova O. A., Skalny A. V., Sotnikova N. Yu., Novicova
E. A. New view upon Cerebrolysin ® effect in children
With minimal cerebral dysfunction // Monreal, Kanada,
May 2002. — 2002. — P. 516.
Grundman M. Current therapeutic advances in Alzheimer ’ s
disease // Research and practice in Alzheimer ’ s disease /
Serdi Publishing (Paris). Springer Publishing Company
(NY). — 2001. — Vol. 5. — P. 172 – 77.
Gschanes A. et al. 1995 — cite by Intrathecal Administration
Of Cer-ebrolysin. — EBEWE, 1998. — 37 р .
Gschanes A. et al. 1996 — cite by Interathecal Administration
Of Cerebrolysin. — EBEWE, 1998. — 41 р .
Gschanes A., Boado R., Sametz W., Windisch M. The
Cerebrolysin and its peptide fraction E021 increase the
Abundance of the blood-brain barrier GLUT1 glucose
Transporter in brains of young and old rats // J. Histochem.
|
|
|
— 2000. — N 32 (2). — Р . 71 – 7.
Gschanes A., Valouskova V., Windisch M. Ameliorative influence
Of a nootropic drug on motor activity of rats after
Bilateral carotid artery occlusion // J. Neural. Transm. — par 1997. — N 104 (11 – 2). — Р . 1319 – 327.
Gschanes A., Windisch M. Early postnatal treatment
With peptide preparations influences spatial navigation
Of young and adult rats // Behav. Brain Res. — 1999. — par N 100 (1 – ). — Р . 161 – 66.
Gschanes A., Windisch M. The influence of Cerebrolysin
And E021 on spatial navigation of 24 monthold rats // J.
Neural. Transm. — 1998. — Vol. 53, Suppl. — P. 313 – 21.
НУu1095 чНu1067 ЫЕОu1041 БЗu1054 ОРu1067 Ы
Оu1041 БЗu1054 ОРu1067 Ы Пu1054 О Кu1051 ЛИu1053 НИu1063 ЧЕu1057 СКu1054 ОЙФu1040 АРu1052 МАu1050 КОu1051 ЛОu1043 ГИu1048 И ИЛu1045 ЕКu1040 АРu1057 СТu1042 ВЕu1053 ННu1054 ОЙТu1045 ЕРu1040 АПu1048 ИИТu1054 ОМ7/2009/4
Gutman B., Hutter-Paier B., Skofitsch G. et al. In vitro
Models of brain ischemia: the peptidergic drug Cerebrolysin
protects chick cortical neurons from cell death //
Neurotoxity Res. — 2002. — N 4(1). — Р . 59 – 5.
Hanines P., Houst’va L., Stejkal L., Dubovy P. Rescue of
Дата добавления: 2018-09-22; просмотров: 146; Мы поможем в написании вашей работы! |
Мы поможем в написании ваших работ!